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Summary: In five severely head-injured patients we determined the plasma concentrations of apolipoproteins
serum amyloid A, A-I, A-II, C-III, and B, prealbumin and C-reactive protein on day 1, 5, 10 and 15 after
head injury where possible. A dramatic increase in apolipoprotein serum amyloid A up to a mean plasma
level of 0.764 g/1 was accompanied by a considerable decrease in apolipoprotein A-I, apolipoprotein A-II and
apolipoprotein C-III concentrations. The variations observed by immunological methods were confirmed by
two-dimensional gel electrophoresis performed on plasma and different lipoprotein fractions. In addition to
its association with high density lipoproteins, apolipoprotein serum amyloid A was also found with lipoproteins
of low and very low density. Two-dimensional electrophoresis also showed the presence of several different
serum amyloid A-peptides not seen in plasmas from healthy subjects. We propose that apolipoprotein serum
amyloid A may be responsible for the decrease of the main HDL apolipoproteins in head-injured patients.
Introduction potent inducer of serum amyloid A synthesis in he-
The acute phase response is a systemic reaction to patocytes (13-16). The mechanism by which inter-
infectious and non-infectious agressive processes. leukin * stimulates the synthesis seems to be a direct
Multiple physiological adaptations occur, including modulation of the expression of the genes coding for
changes in the hepatic synthesis of a number of plasma serum amyloid A (17). Recent studies suggest that
proteins termed acute phase reactants (1). During interleukin 6 and tumour necrosis factor also induce
inflammation, the apolipoprotein composition of acute Phase Protein synthesis (18, 19). Up to six
serum high density lipoprotein particles changes isoforms of serum amyloid A have been identified
markedly. The major apolipoprotein A-I is partially with different isoelectric points ranging between pH
displaced by a protein known either as apolipoprotein ^.2 and 7.4 (20).
S (2 —4) or, more commonly, as apolipoprotein serum Apolipoprotein serum amyloid A is transported in
amyloid A (5 — 9). Serum amyloid A and C-reactive association with high density lipoprotein and may
protein are the most characteristic and sensitive acute represent as much as 25 — 50% of the HDL protein
phase reactants (10, 11). The synthesis of apolipopro- (4, 20 — 22). The effect of the acute response on HDL
tein serum amyloid A, which occurs predominantly is of interest since serum amyloid A catabolism rate
in the liver, increases 500 —1000-fold following an is affected by binding to lipoproteins (23). Malmendier
inflammatory stimulus (10, 12). Macrophage/mono- et al. (24) and others (6, 25) have shown that HDL-
cyte-derived interleukin 1 has been shown to be a serum amyloid A seems to be metabilized more rap-
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idly than other HDL particles. The particles also
containing A-I (Lp A-I: serum amyloid A) have a
much slower turnover rate than the particles not as-
sociated with apolipoprotein A-I (Lp serum amyloid
A) (24).
Several laboratories have recently investigated the
properties of HDL from a variety of inflammatory
disorders (26 — 30). All reported a decrease of apoli-
poprotein A-I concentration. These studies involved
comparisons of HDL from normal subjects with HDL
isolated at a single time-point from patients with a
spectrum of diseases and severity. Effects related to
duration and intensity of the acute phase response
were not evaluated. The fact that lowered HDL con-
centrations have been observed in some studies and
not in others may be due to differences in the severity
of the acute phase responses, or related to the delay
in obtaining the plasma after the onset of inflamma-
tion. Recently, we have observed an approximate 50%
decrease in apolipoproteins A-I, A-II and C-III con-
centrations after severe head injury (31). The purpose
of the present study was to investigate the possible
connection of these apolipoprotein changes with apo-
lipoprotein serum amyloid A and its lipoprotein dis-
tribution in head-injured patients at different times
after the injury.
urea and 20 g/1 Nonidet P40 in the first dimension, and 10 g/1
SDS in the second dimension. Plasma proteins (200 μ§) were
applied to the first dimension gel. For VLDL, LDL, HDL
analysis, the amount of applied proteins was 6.4, 4.8 and 12.8
μ§ respectively.
Apolipoprotein de te rmina t ions
Apolipoprotein serum amyloid A was quantitated using a sand-
wich ELI S A technique (37). Briefly, pure apolipoprotein serum
amyloid A was used as primary standard. The antisera were
prepared by injecting New Zealand White rabbits with two
chemically synthesized short fragments of apolipoprotein serum
amyloid Al corresponding to residues 58 — 69 and 95 — 104 of
apolipoprotein serum amyloid A covalently linked to tetanus
toxoid with glutaraldehyde. The antibodies recognized both
their corresponding peptides and apolipoprotein serum amyloid
A, and were used in the ELISA assay (37). Apolipoprotein C-
III was also quantitated by sandwich ELISA as previously
described (38). The apolipoprotein A-I, apolipoprotein A-II
and apolipoprotein B concentrations were measured by elec-
troimmunoassay using reagents purchased from Sebia (Issy-les-
Moulineaux, France) (39).
CRP and prealbumin deteminat ions
C-reactive protein concentrations were determined by immu-
nonephelometry as previously described (40). Prealbumin
(transthyretin) was assayed with a monospeciflc antibody (Hy-
land Division of Travenol Laboratories, Plaisir, France) diluted
with a solution containing 40 g of polyethylene glycol 6000
(Merck, Hohenbrunnen, FRG) and 150 mmol of NaCl per litre
on a laser PDQ nephelometer Hyland (41).
Materials and Methods
Patients
Five adult patients (3 men, 2 women) were admitted to "Centre
d'Orthopedie et de Traumatologie de Strasbourg" for isolated
severe head injury. They were apparently healthy before trauma.
The patients were daily receiving during their hospitalization a
continuous isocaloric enteral infusion of Nutrison® (Nutricia,
Holland). This infusion consisted of 36% lipids, 16% proteins
and 48% carbohydrates in terms of calories and was supple-
mented with vitamins and minerals. Of the five patients, two
died on day ten after cranial injury, the others survived. Blood
samples were collected from each patient on day 1, 5, 10 after
injury, also on day 15 from the survivors. Samples were cen-
trifuged and the plasmas were stored at — 20 °C until analysis.
In these conditions, no significant lipid or apolipoprotein mod-
ifications were observed.
Lipoprotein f ract ionat ion
Lipoprotein fractions (VLDL, LDL, HDL) were isolated from
fresh plasma samples by sequential preparative ultracentrifu-
gation (32) in a Beckman model L5-50 ultracentrifuge, using a
Beckman 50 Ti rotor. Fractions were collected and dialysed
against a 0.15 mol/1 NaCl solution containing Na2 EDTA
(1 mmol/1) pH 7.4 for 24 h at 4 °C. The protein concentration
of each fraction was determined as described by Bradford (33).
Two-dimensional polyacrylamide gel electrophoresis
Two-dimensional electrophoresis was carried out essentially as
described (34) with some modifications for application to apo-
lipoproteins (35, 36). Apolipoproteins were separated in 8 mol/1
Results
Five head-injured patients were monitored for 15 days
after injury by apolipoprotein measurements on day
1, 5, 10 and 15 (two patients died after day 10, thus
no data exist for these subjects for day 15). The results
are summarized in table 1. Apolipoprotein A-I and
A-II concentrations decreased markedly, while apo-
lipoprotein C-III decreased to a lesser extent and
began to rise again on day 15. Whereas apolipoprotein
A-I continued to decrease until day 10, the levels of
apolipoprotein A-II and C-III had become constant
by day 10, or even started to increase again. In con-
trast, apolipoprotein B concentrations did not change
significantly. Apolipoprotein serum amyloid A and
C-reactive protein increased immediately after injury.
Whereas apolipoprotein serum amyloid A was already
increased on the first day and showed a peak on day
five, the C-reactive protein increase was retarded,
reaching maximal levels on day 10. Prealbumin meas-
ured along with the apolipoprotein parameters also
decreased in the post injury period.
To further determine whether the increase in plasma
levels of apolipoprotein serum amyloid A was due to
a preferential increase of one of the plasma isoforms,
two-dimensional electrophoresis of plasma was car-
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ried out during the study. Figure 1 (a —c) shows the
sequence of changes in plasma proteins from a rep-
resentative patient. In the area which corresponded
to apolipoprotein serum amyloid A isoforms accord-
ing to their physicochemical properties (isoelectric
pH, apparent relative molecular mass), two spots were
observed at day 1 (fig. la). The number and intensity
of these spots were increased mainly on day 5 (fig.
Ib). At this time six spots were detectable, whose
intensity decreased on day 10 (fig. Ic). Figure Id
shows the pattern for a healthy adult; for the same
molecular mass, two spots were apparent which might
correspond to the two ususal apolipoprotein serum
amyloid A isoforms. Thus the increase of apolipopro-
tein serum amyloid A in plasma was accompanied by
the appearance of additional isoforms usually not
detected in plasma. On day 5, only two major apoli-
poprotein serum amyloid A isotypes were detectable
in LDL and VLDL. In contrast, the number and
intensity of apolipoprotein serum amyloid A spots
were more pronounced in HDL (fig. 2). Thus two-
dimensional gel electrophoresis gave some informa-
tion additional to that obtained by the immunological
methods.
Discussion
Apolipoprotein serum amyloid A is normally present
in trace amounts in human plasma but the concen-
tration increases up to 1000-fold as part of an acute
phase response during trauma (27). A tremendous
increase in apolipoprotein serum amyloid A has also
been observed in the patients studied here with severe
head injury.
Several studies have shown that the increase of apo-
lipoprotein serum amyloid A concentration is asso-
ciated with a low level of apolipoprotein A-I and
apolipoprotein A-II or HDL lipids (27, 29). In this
study we confirm the "negative acute phase reactant"
role of apolipoprotein A-I (30) after head injury and
also report a considerable decrease in apolipoprotein
A-II and apolipoprotein C-III. Normally apolipopro-
tein serum amyloid A in plasma is found associated
with lipoproteins, especially with those of high density
(5). Furthermore, isolated apolipoprotein serum amy-
loid A polymorphic forms, like other apolipoproteins,
have been reported to disrupt multilamellar dimyris-
toylphosphatidylcholine liposomes and to generate
bilayer discs (42). In vitro it has been demonstrated
that apolipoprotein A-I can be displaced by apoli-
poprotein A-II from the HDL surface in such a way
that apolipoprotein A-II is transfered from the solvent
phase onto the HDL surface in a concentration-de-
pendent fashion (43). Apolipoprotein serum amyloid
J. Clin. Chem. Clin. Biochem. / Vol. 28, 1990 / No. 8
522 Sa'fle et al.: Apolipoproteins serum amyloid A, A-I, A-II, C-III after head injury
Acid pH Basic pH
Acid pH Basic pH
67000-
34000-
28000-
8800-
b)
Mr
Acid pH Basic pH
67000-
34000- m
28000-
8800-
c)
A/r
67000-
34000-
28000-
8800-
d)
Acid pH Basic pH
Fig. 1. Two-dimensional polyacrylamide gel electrophoresis of
plasma from one head-injured patient on day 1 (a), 5
(b) and 10 (c) after injury in comparison with control
plasma (d).
1: apolipoprotein A-I,
2: cc2 chain of haptoglobin,
3: prealbumin,
4: serum amyloid A,
5: apolipoprotein C,
6: apolipoprotein A-II.
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Fig. 2. Two-dimensional polyacrylamide gel electrophoresis of
HDL (a), LDL (b), and VLDL (c) isolated from the
plasma on day 5 after head injury (same plasma as in
figure 1). For details see legend of figure 1.
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A also seems to be capable of displacing apolipopro-
tein A-I or A-II from lipoprotein particles in a very
similar, concentration-dependent manner. It was con-
cluded that apolipoprotein serum amyloid A had a
higher affinity than apolipoprotein A-I and A-II for
HDL particles (29). Several groups have shown that
the association of apolipoprotein serum amyloid A
mainly with denser HDL3 particles increased their
diameter to form particles that resemble HDL2 in size
(28, 29). The addition of serum amyloid A to HDL
resulted in particles comprising up to 80% of serum
amyloid A in their protein moiety (29).
One mechanism of lowering of HDL apolipoproteins
A-I, A-II and C-III in our study could be their dis-
placement from HDL particles by serum amyloid A.
The displaced apolipoproteins would then have an
increased catabolism. Several laboratories have pos-
tulated that serum amyloid A was incorporated into
HDL and displaced the normal HDL protein. This
theory is based on two observations. Firstly, serum
amyloid A can represent a high proportion of the
HDL proteins without a proportional increase in the
total protein content (9). Secondly, the incorporation
of serum amyloid A into HDL and the concomitant
displacement of apolipoprotein A-I have been dem-
onstrated in vitro (29). Serum amyloid A comprised
as much as 80% of the HDL protein. Only apolipo-
protein A-I was displaced, and the A-II and C protein
content did not change (29).
A further mechanism, simultaneously responsible for
the decrease of HDL apolipoproteins, might be a
reduction of their synthesis during the acute phase
response. Hepatic synthesis of several plasma proteins
is known to decline during the acute phase response.
Bausserman et al. (9) suggested that low HDL levels
during acute phase response could be due to reduced
apolipoprotein synthesis rather than displacement by
serum amyloid A. Baumann et al. (44) showed a
decreased rate of apolipoprotein A-I synthesis in pri-
mary hepatocytes isolated after initiation of acute
inflammation. Also Lowell et al. (45) have reported
that the levels of albumin and apolipoprotein A-I
mRNA decreased 2-fold in cultured rat hepatocytes
after endotoxin administration. Thus several mecha-
nisms, including a direct effect of interleukins 1 and/
or 6, may be responsible for the decrease in normal
HDL apolipoproteins in head-injured patients (46,
47). Studies of HDL apolipoprotein synthesis by the
intact organism and by the liver will be required to
demonstrate reduced apolipoprotein production dur-
ing the acute phase response.
Apolipoprotein serum amyloid A was shown in sev-
eral studies to be a heterogeneous plasma protein (20,
26, 48 — 50). Sequencing data from different apoli-
poprotein serum amyloid A isoforms are compatible
with the hypothesis that there exist at least two genes
coding for apolipoprotein serum amyloid A (51, 52).
cDNA-derived sequences also confirm this view (53,
54). All investigations agree that plasma contains two
dominating apolipoprotein serum amyloid A forms
(serum amyloid Al and A2) and up to four minor
peptides. Under physiological conditions only apoli-
poprotein serum amyloid Al and apolipoprotein
serum amyloid A2 are detectable in trace amounts in
human plasma. During acute phase responses, not
only apolipoprotein serum amyloid Al and apolipo-
protein serum amyloid A2, but also the other isoforms
may increase. In our study, head injury led to the
multiplication and intensification of certain spots
which may correspond to apolipoprotein serum amy-
loid A isoforms. Present results are compatible with
a proportional increase of all isoforms revealing cer-
tain spots already present but in indetectable
amounts. We also showed that mainly apolipoprotein
serum amyloid Al and apolipoprotein serum amyloid
A2 were also associated with LDL and YLDL,
whereas the remaining isoforms seem to associate
predominantly with HDL. Two dimensional gel elec-
trophoresis during the acute phase response could
thus be a tool to monitor the induction of different
isoforms in various diseases and to identify possibly
amyloidogenic apolipoprotein serum amyloid A
forms.
In conclusion, head injury leads to an acute phase
response similar to other inflammatory processes; this
response includes the appearance of several detectable
isoforms of apolipoprotein serum amyloid A in
plasma.
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